-,

Chen Jiang1,2, Li-Yun Huang1,2, Ji-Hao Zhou3

  • 1State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, P.R. China.

iScience
|January 8, 2024
PubMed
概括

结节性硬化症经典霍奇金淋巴瘤 (NScHL) 细胞中的爱普斯坦-巴尔病毒 (EBV) 感染与患者的结局有关. 使用EBV编码小RNA (EBER) 的新模型预测了接受ABVD治疗的NScHL患者的无进展和整体存活率.